This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 41301690
Submitted by lobbyist on: September 24, 2018 09:48:36 PM
Accepted by Registrar on: September 25, 2018 09:21:08 AM
Lobbyist Information
Cunningham, Michael |
939 Boulderwood Rise | |
Victoria, BC, V8Y 3G5
|
250-744-7435 |
Canada |
BC Public Office Background
Public Office Title | Description of Role | From | To |
---|---|---|---|
Political Staff | Ministerial Assistant | 06/04/2001 | 02/20/2004 |
Lobbyist Firm Information
Graphite Public Affairs |
939 Boulderwood Rise | |
Victoria, BC, V8Y 3G5
|
250-744-7435 |
Canada |
Client Information
Biosimilars Working Group |
The Biosimilars Working Group is a key collaboration of diverse non-profit organizations, registered health charities, and health care advocacy coalitions who are dedicated to ensuring that good outcomes for patients are at the centre of health policy in Canada, specifically in the biologic medication treatment areas. |
231-3665 Kingsway | |
Vancouver, BC, V5R 5W2
|
604-873-4876 |
Canada |
Relevant Affiliates
Type:
Business Name | Mailing Address | Contact Information |
---|---|---|
Canadian Council of the Blind |
100-20 James Street
Ottawa, ON K2P 0T6 Canada |
Phone: |
Canadian Psoriasis Network |
167 Church Street
Toronto, BC M5B 1Y6 Canada |
Phone: |
Crohn's and Colitis Canada |
600-60 St. Clair Avenue East
Toronto, ON M4T 1N5 Canada |
Phone: |
Gastrointestinal Society |
231-3665 Kingsway
Vancouver, BC V5R 5W2 Canada |
Phone: 604-873-4876 |
Government or Government Agency Funding
The organization does not receive any funding from a government or government agency.
Other Controlling or Directing Interests
The organization has no other controlling or directing interests.
Undertaking Information
September 15, 2018 | |
March 31, 2019 |
There are no other individuals engaged to lobby on this undertaking.
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
To ensure patient outcomes and considerations are at the centre of health policy discussions in the biologics treatment space
Target Contacts
Target Type | Name | Title or Constituency | Date Added |
---|---|---|---|
Minister | Dix, Adrian | Minister of Health | September 24, 2018 |
Public Agency | Health | September 24, 2018 |